International Medical Graduate Challenges: Narjust Florez, MD | Dana-Farber Cancer Institute

Q & A with EGFR-Mutant Lung Cancer Experts | 2024 Living with EGFR-Mutant Lung Cancer Patient ForumПодробнее

Narjust Florez, MD, on Thoracic Cancer Treatment | Dana-Farber Cancer InstituteПодробнее

Bridging Academia and Industry to Fight Diseases | Dana-Farber Cancer InstituteПодробнее

Developing & Implementing Cancer Prevention, Treatment and Survivorship Guidelines & Closing RemarksПодробнее

Challenges associated with developing treatments for solid and rare tumorsПодробнее

What Are Some of the Unique Challenges that Brain Tumor Patients Face?Подробнее

Reflections on Working at Dana-Farber Cancer InstituteПодробнее

International perspectives in U.S. cancer center leadershipПодробнее

Challenges faced by women with lung cancerПодробнее

Treating patients as a team: Dr. Andrew Norden | Dana-Farber Cancer InstituteПодробнее

Bridging Academia & IndustryПодробнее

50 Years: Dana-Farber/Mass General Brigham Fellowship in Hematology/OncologyПодробнее

Edward J. Benz, Jr., MD - Oral History | Dana Farber Cancer InstituteПодробнее

Dr. Palakurthi on Strategies for Managing Resistance to Osimertinib in Patients With NSCLCПодробнее

Multiple Myeloma Symposium: Bone Health | Dana-Farber Cancer InstituteПодробнее

Dana-Farber Cancer Institute Post Doc Tony BarnitzПодробнее

Why do Basic Research in a Cancer Institute? | Dana-Farber Cancer InstituteПодробнее

Forum for Young Women with Breast Cancer 2018, Research | Dana-Farber Cancer InstituteПодробнее